Does Glyphosate Affect the Gut Microbiome? What Research Shows About Leaky Gut and Akkermansia

Quick Answer: Does glyphosate harm the gut microbiome?

Possibly, under some conditions, but the human picture is not settled. Glyphosate works by blocking an enzyme (EPSPS) in the shikimate pathway, which plants and many bacteria use but human cells do not. Animal and laboratory studies suggest that glyphosate, or some glyphosate-based herbicide formulations, can alter microbial and intestinal parameters at certain doses. Whether these findings translate into clinically meaningful effects in people remains uncertain, and major regulators disagree about glyphosate's broader safety. Akkermansia muciniphila is studied for its role in the gut barrier, but it is not a proven glyphosate detox or a way to reverse glyphosate exposure, and no supplement should be treated as a treatment for chemical exposure. If you have had a significant exposure or symptoms, contact a healthcare professional or Poison Control rather than relying on a supplement.

Understanding Glyphosate and the Gut Microbiome

Glyphosate, the active ingredient in Roundup, is the most widely used herbicide in the world, so questions about its effect on the gut are reasonable and common. It was considered low-risk for people because its target, the shikimate pathway, is not found in human cells.

The nuance that matters is what this means for gut bacteria. It is often said that most of our gut microbes use the shikimate pathway, but that overstates the case. Analyses of large sets of human gut metagenomes suggest that most gut bacteria do not carry a fully active shikimate pathway and instead obtain aromatic amino acids from the diet, which would make them relatively less exposed to this particular mechanism (Mesnage 2020, human metagenome analysis). Some species are more susceptible than others, so the honest position is that the gut is partly, not uniformly, exposed. For background on the barrier itself, see our gut barrier and intestinal permeability hub.

How Glyphosate Works: EPSPS and the Shikimate Pathway

Glyphosate inhibits the enzyme 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), blocking the synthesis of aromatic amino acids through the shikimate pathway. This is a well-established mechanism in plants and in bacteria that rely on the pathway. It is important to be precise about the next step: inhibiting EPSPS in some bacteria does not automatically equal dysbiosis in a person. Whether meaningful microbial change occurs depends on the dose, the duration, the species present, and whether those species use the pathway at all.

Laboratory work has shown that some beneficial genera, including Lactobacillus and Bifidobacterium, can be sensitive to glyphosate in culture, while certain other bacteria are more resistant. These are in vitro observations, and predicting how they play out in a living, competitive gut community is not straightforward. A further distinction matters throughout this topic: glyphosate alone and finished glyphosate-based herbicide formulations are not the same thing. Some formulations contain co-formulants (such as surfactants) that can be more biologically active than glyphosate itself, so results from one do not automatically apply to the other.

What the Human Evidence Shows (and Doesn't)

This is where careful separation of evidence types is essential. Most of what we know about glyphosate and the gut microbiome comes from animals and laboratory models, not from people.

In rodents, studies have reported changes in microbial composition and signs of shikimate-pathway inhibition in the gut after exposure to glyphosate or Roundup at various doses, including doses described as regulatory reference levels (Mao 2018, animal; Mesnage 2021, animal metagenomics). These are meaningful signals worth studying, but they are rodent studies, and effects varied by dose and by whether glyphosate or a formulation was used.

In humans, the direct evidence is limited. The clearest human-relevant work analyzes gut metagenomes and estimates how many species could be susceptible, rather than measuring health outcomes (Mesnage 2020). What the evidence does not currently show is that ordinary dietary glyphosate exposure causes leaky gut and, through it, autoimmune disease in people. Increased intestinal permeability is studied in relation to many factors, and a direct glyphosate-to-autoimmunity chain in humans is not established. It is more accurate to say this is an open research question than a demonstrated harm.

The Regulatory Picture

It also helps to know where regulators stand, because they do not fully agree. In 2015, the International Agency for Research on Cancer (IARC) classified glyphosate as "probably carcinogenic to humans" (Group 2A). In contrast, the US Environmental Protection Agency has concluded glyphosate is unlikely to be a human carcinogen, and the European Food Safety Authority and the European Chemicals Agency concluded it does not meet the criteria to be classified as a carcinogen. In 2023, the European Union renewed glyphosate's approval for ten years, with conditions, and that decision remains contested. These bodies were assessing cancer risk rather than gut-microbiome effects specifically, but the disagreement is a useful reminder that this is a genuinely debated area.

Why Studies Disagree

Several honest reasons explain why studies and experts reach different conclusions:

• Glyphosate versus formulations. Finished herbicide products contain co-formulants that can be more active than glyphosate alone, so studies of different test articles can diverge.

• Dose and exposure. Effects seen at high or prolonged exposures may not apply to typical dietary residue levels.

• Models and endpoints. Rodents, cell cultures, and computational analyses answer different questions, and rodent gut communities differ from ours.

• Hazard versus risk. A hazard classification describes what a substance could do in principle; a risk assessment weighs real-world exposure. Agencies weigh these differently.

None of this means the concern is baseless. It means the responsible reading is cautious and specific, not alarmist and not dismissive.

Where Akkermansia Fits Into Gut-Barrier Research

Akkermansia muciniphila lives in the intestinal mucus layer, where it uses mucin as a carbon and nitrogen source and interacts with the cells that form the gut barrier (Derrien 2004, species description). That original paper describes and characterizes the bacterium; it does not, on its own, prove that Akkermansia regenerates a damaged barrier. It is the starting point for a large body of later research, not the proof of a clinical effect.

From there, the evidence is a mix of animal and human work, and it is worth labeling. In mice, an Akkermansia membrane protein (Amuc_1100) and the pasteurized bacterium improved tight-junction markers and metabolism (Plovier 2017, animal); this is promising mechanism, but it is animal data and cannot answer the question "do probiotics heal leaky gut?" in humans. In a human proof-of-concept trial, pasteurized Akkermansia improved insulin sensitivity and some inflammatory markers in overweight adults (Depommier 2019, human); that trial was about metabolic markers, not glyphosate. Akkermansia also takes part in cross-feeding: by breaking down mucin it releases metabolites that can feed butyrate-producing bacteria, and butyrate is an important energy source for colon cells. For more, see the science on Akkermansia benefits.

The Evidence at a Glance

A quick guide to where the science stands, and what kind of evidence supports each point.

Can Akkermansia Resist or Reverse Glyphosate?

Some rodent research has looked at how Akkermansia responds to glyphosate exposure, and the results are mixed. In one rat metagenomics study, Akkermansia was actually higher after glyphosate or Roundup exposure (Mesnage 2021, animal), while other rodent work has reported lower Akkermansia alongside herbicide exposure. Because the direction is inconsistent, it is not accurate to read an increase as a deliberate protective adaptation or to call Akkermansia a front-line repair agent. It is better to say that its response to glyphosate is still being characterized.

What follows from that is modest. There is no human evidence that Akkermansia, from food or a supplement, reverses glyphosate exposure or detoxifies glyphosate. Supporting general gut health through diet is sensible, but it should not be presented as a glyphosate remedy.

Where a Supplement Fits

Diet and everyday habits come first. A varied, fiber-rich diet supports the mucus layer and the bacteria that keep the gut barrier healthy, and no supplement replaces that. Next-Microbiome makes Akkermansia Chewable, a chewable that delivers live Akkermansia muciniphila with prebiotics and supporting nutrients, sold through akkermansia.life (the brand and store, not a separate product).

To be accurate about what that means: Akkermansia supplementation is studied mainly for gut-barrier and metabolic markers, not as a treatment or detox for chemical exposure. Treat a product like this as general microbiome support that sits alongside a healthy diet, not as a way to counter glyphosate. If you are pregnant, nursing, managing a health condition, or taking medication, check with a clinician first.

The Bottom Line

Glyphosate acts on a bacterial enzyme that people do not have, and animal and laboratory studies suggest it, or some of its formulations, can alter gut and intestinal measures under certain conditions. Whether that translates into meaningful effects in humans is still uncertain, regulators disagree on glyphosate's broader safety, and the strongest microbiome data remain preclinical.

Akkermansia muciniphila is a genuinely interesting bacterium for gut-barrier and metabolic research, and supporting a healthy microbiome through diet is a reasonable thing to do. What the evidence does not support is presenting Akkermansia, or any supplement, as a way to detox or reverse glyphosate exposure. If you are worried about a specific exposure or have symptoms, that is a question for a healthcare professional, not a supplement.

Frequently Asked Questions About Glyphosate and Gut Health

1. Does glyphosate cause leaky gut?

The honest answer is that it is not established in humans. Animal and laboratory studies suggest glyphosate or some glyphosate-based formulations can affect intestinal and microbial measures under certain conditions, and increased intestinal permeability is studied in relation to many factors. A direct, proven glyphosate-to-leaky-gut chain in people is not something current human evidence demonstrates.

2. Can probiotics or Akkermansia reverse glyphosate exposure?

There is no human evidence that a probiotic, including Akkermansia, reverses glyphosate exposure or detoxifies glyphosate. Akkermansia is studied for gut-barrier and metabolic markers, not as a treatment for chemical exposure. Supporting general gut health with a varied, fiber-rich diet is reasonable, but it is not a glyphosate remedy.

3. Can a doctor test you for glyphosate exposure?

Tests can measure glyphosate in blood or urine, but ATSDR notes these are not part of a standard doctor's office workup. They may only reflect very recent exposure, and they cannot tell you your lifetime exposure or predict whether you will develop health problems. Symptoms, exposure history, and medical evaluation matter more than trying to use a single test result as a complete answer (ATSDR ToxFAQs, glyphosate).

4. When should someone seek medical help after possible glyphosate or weed-killer exposure?

Seek help promptly if concerning symptoms develop after exposure, especially vomiting, trouble breathing, eye pain or burning, worsening skin irritation, dizziness, weakness, muscle twitching, or changes in alertness. ATSDR notes that swallowing a large amount of glyphosate can cause nausea and vomiting and that it can irritate the skin and eyes. Poison Control reports that glyphosate products can cause chemical burns, including serious eye injury, so do not delay evaluation after a significant splash or ingestion (Poison Control, lawn chemicals; HealthyChildren, protecting children from pesticides).

Scientific References

1. Mesnage R, Antoniou MN.
   Facts and Fallacies in the Debate on Glyphosate Toxicity
   Frontiers in Public Health. 2017;5:316
   doi:10.3389/fpubh.2017.00316 (Review of the toxicity debate)

2. Mesnage R, Antoniou MN.
   Computational modelling provides insight into the effects of glyphosate on the shikimate pathway in the human gut microbiome
   Current Research in Toxicology 2020;1:25-33
   doi:10.1016/j.crtox.2020.04.001 (Analysis of human gut metagenomes)

3. Mao Q, Manservisi F, Panzacchi S, et al.
   The Ramazzini Institute 13-week pilot study on glyphosate and Roundup administered at human-equivalent dose to Sprague Dawley rats: effects on the microbiome
   Environmental Health 2018;17(1):50
   doi:10.1186/s12940-018-0394-x (Animal study)

4. Mesnage R, Teixeira M, Mandrioli D, et al.
   Use of Shotgun Metagenomics and Metabolomics to Evaluate the Impact of Glyphosate or Roundup MON 52276 on the Gut Microbiota and Serum Metabolome of Sprague-Dawley Rats
   Environmental Health Perspectives 2021;129(1):017005
   doi:10.1289/EHP6990 (Animal metagenomics and metabolomics)

5. Derrien M, Vaughan EE, Plugge CM, de Vos WM.
   Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium
   International Journal of Systematic and Evolutionary Microbiology 2004;54(Pt 5):1469-1476
   doi:10.1099/ijs.0.02873-0 (Species description)

6. Plovier H, Everard A, Druart C, et al.
   A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice
   Nature Medicine 2017;23(1):107-113
   doi:10.1038/nm.4236 (Animal study)

7. Depommier C, Everard A, Druart C, et al.
   Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
   Nature Medicine 2019;25(7):1096-1103
   doi:10.1038/s41591-019-0495-2 (Human randomized pilot; metabolic markers)

Written by Ali Rıza Akın

Microbiome Scientist, Author & Founder of Next-Microbiome

Ali Rıza Akın is a microbiome scientist with nearly 30 years of experience in translational biotechnology, systems biology, and applied microbiome research, spanning discovery, preclinical development, and clinical-stage translation.

His work focuses on how microbial ecosystems interact with human physiology, including:

• Gut barrier function and intestinal permeability

• Mucus-associated microbiota (Akkermansia-related systems)

• Oral–gut microbiome axis

• Short-chain fatty acids (SCFAs) and metabolic signaling

• Circadian rhythm–microbiome interactions

• Clinical Research Contributions

He has contributed to multiple clinical-stage microbiome programs, supporting bacterial strain discovery, optimization, and formulation design across different therapeutic areas, including:

Active Ulcerative Colitis (Inflammatory Bowel Disease)

Hyperoxaluria (Oxalate Metabolism Disorder)

Microbiome-driven gut health and inflammatory conditions

These studies were part of broader clinical development programs evaluating microbiome-based approaches. His contributions focused on the early-stage scientific and translational pipeline, including strain discovery, functional optimization, and multi-strain formulation design.

Scientific Contributions:

Ali Rıza Akın is the discoverer of Christensenella californii, a bacterial species associated with microbiome diversity and metabolic health.

He is a contributing author to scientific publications and Bacterial Therapy of Cancer (Springer), and the author of Bakterin Kadar Yaşa: İçimizdeki Evren: Mikrobiyotamız.

Approach:

His work emphasizes evidence-based microbiome science, long-term safety, and a systems-based understanding of how microbes influence human health.

Review and Sources

This article is written and reviewed by a microbiome scientist and is based on the peer-reviewed studies and public-health sources listed in the References and the FAQ. Established mechanisms, animal studies, human analyses, and areas of insufficient evidence are labeled throughout, so readers can weigh each claim. It is reviewed periodically against current research and regulatory positions.

Medical Disclaimer

This content is for educational and informational purposes only and is not medical advice. It does not diagnose, treat, cure, or prevent any disease or condition, and it is not a guide to treating chemical or pesticide exposure. Dietary supplements, including Akkermansia products, are not a treatment for glyphosate exposure and do not detoxify or reverse it. If you have had a significant exposure to glyphosate or any weed killer, or you develop symptoms such as vomiting, trouble breathing, eye or skin injury, or changes in alertness, contact a healthcare professional or your local Poison Control center right away. Consult a qualified healthcare professional before starting any new supplement, especially if you are pregnant, nursing, managing a health condition, or taking medication.

Last reviewed: August 2026